Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
?14.06
 
WKN: A2PL3P / Symbol: ONCT / Name: Oncternal Therapeutics / Stock / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Oncternal Therapeutics Inc. Stock

Currently there is a rather negative sentiment for Oncternal Therapeutics Inc. with 4 Buy predictions and 20 Sell predictions..
On the other hand, the target price of 14 € is above the current price of 0.32 € for Oncternal Therapeutics Inc., so the potential is actually 4330.38%.
Our community identified positive and negative aspects for Oncternal Therapeutics Inc. stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Oncternal Therapeutics Inc. stock. On the other hand our users think that "Unique positioning" could be a problem in the future.

Pros and Cons of Oncternal Therapeutics Inc. in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
B****
Cons
?
C******** o* t** e**********
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Prediction Buy
Perf. (%) -
Target price 26.281
Change
Ends at 15.04.25

Oncternal Therapeutics, Inc. (NASDAQ: ONCT) had its price target lowered by analysts at HC Wainwright from $30.00 to $28.00. They now have a "buy" rating on the stock.
Ratings data for ONCT provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -
Target price 27.720
Change
Ends at 29.01.25

Oncternal Therapeutics, Inc. (NASDAQ: ONCT) had its price target raised by analysts at HC Wainwright to $30.00. They now have a "buy" rating on the stock.
Ratings data for ONCT provided by MarketBeat
Show more

Oncternal Therapeutics, Inc. (NASDAQ: ONCT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ONCT provided by MarketBeat
Show more